These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 16211298

  • 1. C2-ceramide exhibits antiproliferative activity and potently induces apoptosis in endometrial carcinoma.
    Takai N, Ueda T, Kawano Y, Nishida M, Nasu K, Narahara H.
    Oncol Rep; 2005 Nov; 14(5):1287-91. PubMed ID: 16211298
    [Abstract] [Full Text] [Related]

  • 2. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2006 Feb; 17(2):323-9. PubMed ID: 16391833
    [Abstract] [Full Text] [Related]

  • 3. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
    Ueda T, Takai N, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
    [Abstract] [Full Text] [Related]

  • 4. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2008 May; 21(5):637-43. PubMed ID: 18425357
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells.
    Ahn MY, Lee J, Na YJ, Choi WS, Lee BM, Kang KW, Kim HS.
    Chem Biol Interact; 2009 May 15; 179(2-3):169-77. PubMed ID: 19070610
    [Abstract] [Full Text] [Related]

  • 6. Histone deacetylase inhibitors induce growth inhibition, cell cycle arrest and apoptosis in human choriocarcinoma cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2008 Jan 15; 21(1):109-15. PubMed ID: 18097623
    [Abstract] [Full Text] [Related]

  • 7. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
    Ahn MY, Jung JH, Na YJ, Kim HS.
    Gynecol Oncol; 2008 Jan 15; 108(1):27-33. PubMed ID: 17920664
    [Abstract] [Full Text] [Related]

  • 8. K252a is highly effective in suppressing the growth of human endometrial cancer cells, but has little effect on normal human endometrial epithelial cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Oncol Rep; 2008 Mar 15; 19(3):749-53. PubMed ID: 18288411
    [Abstract] [Full Text] [Related]

  • 9. Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis.
    Takai N, Kawamata N, Gui D, Said JW, Miyakawa I, Koeffler HP.
    Cancer; 2004 Dec 15; 101(12):2760-70. PubMed ID: 15536623
    [Abstract] [Full Text] [Related]

  • 10. CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Matsuda K, Kusumoto M, Narahara H.
    Oncology; 2006 Dec 15; 70(2):97-105. PubMed ID: 16601366
    [Abstract] [Full Text] [Related]

  • 11. Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nasu K, Narahara H.
    Gynecol Oncol; 2008 Nov 15; 111(2):336-43. PubMed ID: 18790523
    [Abstract] [Full Text] [Related]

  • 12. Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Gynecol Oncol; 2008 Apr 15; 109(1):107-14. PubMed ID: 18234298
    [Abstract] [Full Text] [Related]

  • 13. Effect of mifepristone on proliferation and apoptosis of Ishikawa endometrial adenocarcinoma cells.
    Li A, Felix JC, Minoo P, Amezcua CA, Jain JK.
    Fertil Steril; 2005 Jul 15; 84(1):202-11. PubMed ID: 16009178
    [Abstract] [Full Text] [Related]

  • 14. Activation of telomerase and cyclooxygenase-2 in PDGF and FGF inhibition of C2-ceramide-induced apoptosis.
    Chien CC, Shen SC, Yang LY, Wu CY, Liau JS, Chen YC.
    J Cell Physiol; 2009 Feb 15; 218(2):405-15. PubMed ID: 18932216
    [Abstract] [Full Text] [Related]

  • 15. In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines.
    Navo MA, Smith JA, Gaikwad A, Burke T, Brown J, Ramondetta LM.
    Cancer Chemother Pharmacol; 2008 Aug 15; 62(3):483-9. PubMed ID: 18004570
    [Abstract] [Full Text] [Related]

  • 16. Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells.
    Pruschy M, Resch H, Shi YQ, Aalame N, Glanzmann C, Bodis S.
    Br J Cancer; 1999 May 15; 80(5-6):693-8. PubMed ID: 10360645
    [Abstract] [Full Text] [Related]

  • 17. Induction of apoptosis by sphingosine, sphinganine, and C(2)-ceramide in human colon cancer cells, but not by C(2)-dihydroceramide.
    Ahn EH, Schroeder JJ.
    Anticancer Res; 2010 Jul 15; 30(7):2881-4. PubMed ID: 20683027
    [Abstract] [Full Text] [Related]

  • 18. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY, Chang JW, Chou WC, Liaw CC, Wang HM, Huang JS, Wang CH, Yeh KY.
    Lung Cancer; 2008 Feb 15; 59(2):180-91. PubMed ID: 17900752
    [Abstract] [Full Text] [Related]

  • 19. Endometrial cancer cell survival and apoptosis is regulated by protein kinase C alpha and delta.
    Haughian JM, Jackson TA, Koterwas DM, Bradford AP.
    Endocr Relat Cancer; 2006 Dec 15; 13(4):1251-67. PubMed ID: 17158769
    [Abstract] [Full Text] [Related]

  • 20. Anticancer activity of MS-275, a novel histone deacetylase inhibitor, against human endometrial cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Anticancer Res; 2006 Dec 15; 26(2A):939-45. PubMed ID: 16619490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.